Scientists probe immune cell shifts in ICU patients to unlock sepsis secrets
NCT ID NCT07680816
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study examines how a type of immune cell called gamma delta T cells adapt and function in critically ill patients, both with and without sepsis. Researchers will compare these cells in healthy people, non-septic ICU patients, and septic ICU patients. The goal is to understand why the immune system sometimes fails in sepsis, which could lead to better treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could point toward new treatments for immune problems in sepsis and critical illness.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to direct therapies, and findings may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple protein tame Sepsis's fiery inflammation?
- Can we optimize antibiotic dosing for children with sepsis?
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Could starting feeds sooner shield preterm babies from infection?
- AI may predict transfusion needs to shield ICU patients from organ failure
- A simple blood test trend may flag ICU patients at risk